Introduction
Antimicrobial resistance threatens the prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses, and fungi.A ni ncreasing number of governments aroundt he world are devoting efforts to this problem,whichissoseriousthat it threatens the achievements of modern medicine. Far from being an apocalyptic fantasy,a post-antibiotic era in which common infections and minor injuries can kill is ar eal possibility for the 21st century. Ar ecent WHO reportm akes ac lear case that resistance to common bacteria has reached alarming levelsi nm any parts of the world, and that in some settings few,i fa ny,o ft he available treatment optionsr emaine ffective for common infections. Another important finding of the report is that surveillance of antibacterial resistance is neither coordinated nor harmonized and there are many gaps in information regardingb acteria of major public health importance. [1] The intensiveu se of antibiotics for the treatment of numerous bacterial infections is one of the biggest healthcare advances in modernt imes. Nevertheless, their widespread use has led to an increasing number of antibiotic-resistant bacteria. [2] In particular, the emergence of Gram-negative multidrug-resistant (MDR) bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae,h as promptede fforts to develop new classes of antibiotics andc hemosensitizers (moleculest op romote an increase in the internal antibiotic concentration in resistants trains). Thus, diseases caused by MDR Gram-negative bacteria are increasing worldwide, [3, 4] andt he emergence of pan drug-resistant( PDR) bacteria (resistant to all classes of antibioticsa nd to quaternary ammonium disinfectants) [5] appears to have reached ap oint of no return. [6, 7] We have noticed great concern in the medical community,a sn umerous recent clinical reports have confirmed that Gram-negative bacteria have developed resistance to polymyxins, the last efficient therapy against PDR Gram-negative bacteria. [8] [9] [10] An appealingt arget is the unique structureo ft he bacterial membrane, which is highly conserved among most species of Gram-negative bacteria, and forms an effective barrier to many types of antibiotics. [11] Indeed, the acquisition of resistance to membrane-active antibiotics has likely requiredm ajor changes in membrane structure. Ironically,modifications to the bacterial membrane to escape membrane-targetingantibiotics might increaset he permeability of the barrier and actually increase the susceptibility of the bacteria to hydrophobic antibiotics.
It is well establishedt hat mosti mmuner esponses to Gramnegative bacteria involver ecognition of lipopolysaccharides (LPS) and their lipid Aa nchors, which constitute the major components of the outer membrane. [12] [13] [14] [15] [16] [17] The permeability barriero ft he outerm embrane is due to the cross-bridging electrostatic interactions between lipid Am olecules and divalent cations such as calcium or magnesium. [12] We speculated that cationic peptides [18] and polyamines [19] could out-compete these divalent cations for their membrane binding sites and disrupt the outer membrane organization,t hereby increasing Dihydromotuporamine Ca nd its derivatives were evaluated for their in vitro antimicrobial activities and antibiotic enhancement properties against Gram-negative bacteria and clinical isolates.T he mechanism of action of one of these derivatives, MOTU-N44,w as investigated against Enterobacter aerogenes by using fluorescent dyes to evaluate outer-membrane depolarization and permeabilization. Its efficiency correlatedw ith inhibitiono fd ye transport, thus suggesting that these molecules inhibit drug transportersb yd e-energization of the efflux pump rather than by direct interaction of the molecule with the pump. This suggests that depowering the efflux pump provides another strategy to address antibiotic resistance. permeability.B ecause of the promisinga pplications of polyamine derivatives in medicine, [20] [21] [22] we evaluated as eries of hydrophobic polyamine derivatives for their ability to target the membrane stability of Gram-negative bacteria and increaset he sensitivity of these bacteria to known antibiotics.
The motuporamines (originally isolated from the marine sponge Xestospongia exigua) [23] weres elected because their amphiphilic architecturescomprise alarge hydrophobic macrocycle with an appended polyamine motif (1-3,S cheme 1). A series of motuporamine derivatives (4-6)w as prepared [24, 25] along with as eries of relateda nthracenyl-polyamine derivatives (7a-d). These amphiphilic polyamines have large hydrophobic substituentst of acilitate interaction with the bacterial membrane.
Here, 4-6 and 7a-d were screened for their in vitro antimicrobial activities and antibiotic-enhancement properties against resistant Gram-negative bacteria. We also explored the mechanism of action of this class of derivatives against Enterobacter aerogenes (EA289) by using fluorescentd yes, in order to evaluatec hanges in outer-membrane depolarization and permeabilization.
Results and Discussion
Our investigations began with the determinationo ft he minimum inhibitory concentrations (MICs) of 4-7 in Gram-positive and -negative species, in order to identify the concentrations that produce ad irect antibacterial effect and allowed us to rank their relative potencies. We included two Gram-negative bacteria encountered in hospitals, P. aeruginosa and Klebsiella pneumonia,a nd multidrug-resistant E. aerogenes EA289 (Table 1) . Several compounds showed MICs of 100-200 mm for these bacterial strains. The anthracenyl compounds 7a-d had relativelyw eak antimicrobial activities, whereas their related motuporamine derivatives 4a-b, 5a-b,a nd 6a-b showed MICs of 1.56-50 mm.S pecifically, 6a (MOTU-CH 2 -33) and 6b (MOTU-CH 2 -44) exhibited excellent antimicrobiala ctivities against many species, including the multidrug-resistant E. aerogenes EA289.
As stated previously,t he development of chemo-sensitizing agents, which enhancet he intracellular antibiotic concentration in resistants trains (or by other mechanisms) is an attractive approach to overcome bacterial resistance. Thus, we investigated the use of these polyamine derivatives as adjuvantsi n combination with antibiotics. Successh ere would provide an exciting approachtoincrease the potency of current antibacterial drugs, even for strains that have developed resistance.
We investigated whether these polyaminea gents could restore the potency of the antibiotic doxycycline at significantly below its MIC. For example, in our hands the MIC of doxycycline against P. aeruginosa PAO1 was 16 mgmL À1 ,s ow ei nvestigated the use of doxycyclinea tasignificantly lower concentration (2 mgmL
À1
,c orresponding to its pharmacokinetic properties in humans) [6] in the presenceo ft he polyamine derivatives. We speculated that the polyamine agents would disrupt bacterial membrane integrity andi ncreasea ntibiotic delivery to the bacteria and thus increased oxocycline potency. Rewardingly, even at this lowd oxycycline concentration,e ight of the polyamine derivativesr estored doxycycline activity against E. aerogenes EA289, P. aeruginosa PAO1, and K. pneumoniae KPC2-ST258;n oi mprovement was observed for 7b (ANT4) or 7a (ANT-N-butyl)e ven at 40 mm (Table2). The factt hat this effect was compound-specificw as intriguing and ruled out an onspecific detergent effect, especially because no cell lysis was observed.
Several of the effective compounds also acted synergistically with chloramphenicol and erythromycin,p articularly against PAO1, but weakly against EA289 and KPC2-ST258 (Table3). Thus, we identified two groups of compounds:o ne (7a and 7b)d isplayed weak or no activity,a nd the second (e.g., 5a and 5b)i ncreased the antibiotic susceptibility effectively against PAO1. Overall, 5a and 5b appeared the most promising adjuvants for use with doxycycline; 5b (MOTU-N44)w as chosen to investigate the mechanism of action of this molecular class.
Within the motuporamines eries (4-6)s everal compounds exhibited moderate to good antibacterial activity as well as potent synergyw ith different antibioticsa gainst Gram-negative bacteria.W ee xplored the mechanism of action of these compounds and focused on two possible pathways:p ermeabilization and/or disruption of the outer membrane,a nd inhibition of an efflux pump.
First, we determined the effect of 5b on Staphylococcus aureus ATCC25923 by measuring ATPr eleasef or 1min:t here was dramatic disruption of the bacterial membrane, similar to that by squalamine (positive control;F igure 1). [26] Conversely, no significant effect was found for the polyamine spermine (negative control).
As we observed different compound performance in the assays with S. aureus in Ta ble 1, we speculated that some of these molecules might achieve lethality by increasing the rate of transport of molecules across the cytoplasmic membrane, whereas others might not. We surmised that compounds like 5b might induce as maller membrane breach, modestly affect the permeability barrier of the cytoplasmic membrane and cause membrane depolarization. Indeed, as mall breach would allow the passage of electric current (thereby causingm embrane depolarization) withouta llowing the passage of larger molecules. This alternative mechanism seemed plausible because depolarization would de-energize the efflux pump and also lead to increased potencyo ft he antibiotic agent. Therefore, we investigated whether these molecules generated Fluorescent cyanine dyes are excellent probest om onitor membrane depolarization. These dyes lose fluorescencei ntensity when in polarized membranes and become highly fluorescent once polarization is lost. [27] Thus, one can use changes in dye fluorescencet om onitorc hange in membrane polarization. Interestingly,s trong depolarization of S. aureus membranes was observed after 21 minutes as as trong increasei nr elative fluorescent units (RFU) of the cyanine dye (Figure 2) in the presenceo f5b.T his suggests that 5b facilitated membrane depolarization.
Next, 5b wasi nvestigated for its ability to alter the cell outer membrane integrity of E. aerogenes EA289, by using nitrocefin, ac hromogenic b-lactam that is efficiently hydrolyzed by periplasmic b-lactamases, thereby resulting in as ignificant color change from yellow to red. [28, 29] Thus,c olorimetric changes were used to monitoro uterm embrane integrity.E ven at al ow concentration (3.9 mm), 5b increased the rate of nitrocefin hydrolysis compared to the spermine-treated or untreated control (Figure 3a) . The behavior was similar to that of the positivec ontrol polymyxin-B (PMB)w hich also produced an increase in nitrocefinh ydrolysis. All these data suggest that 5b is able to permeabilizeo rd isrupt the outer membrane of Gram-negative bacteria as no cell lysis was observed.
The drug-resistantb acterium EA289o verexpresses the AcrAB-TolC pump, [30] which belongs to the RND efflux pumps and uses the proton gradienta cross the inner membrane as an energy source.I no rder to determine if 5b could act as a disruptoro ft he transmembrane potential, we used the membrane-potential-sensitive probe DiSC 3 (5) which concentrates at the inner membrane and self-quenches its fluorescence. [31] When ac ompound impairs the membrane potential, the dye is released into the growth medium thus leading to af luorescence increase. Treatment with 5b resulted in dose-dependent depolarization after 10 min of incubation (Figure 3b) , thus suggesting disruption of the proton gradient and an ability to affect efflux pumps from the RND family such as AcrAB-TolC.
As imilaro utcome was observed when using ab ioluminescence method to determine the release of intracellular ATP. Additiono f5b caused dose-dependent permeabilization (Figure 3c) . Interestingly,1 0mgmL
À1 5b caused 11 %A TP release into the medium after af ew seconds, thus suggesting rapid disruption.
In general, efflux systems employa ne nergy-dependent mechanism (active transport) to pump out unwanteds ubstances such as toxins, antibiotics, or dyes, through specific efflux pumps. [32] Some efflux systems are drug-specific,w hereas otherse ject multiple drugs, and thus contribute to MDR. Efflux pumps are proteinaceous transporters in the cytoplasmic membrane of bacteria and are active transporters;t hus they require as ource of chemical energy.S ome are primary active transporters that use ATPh ydrolysis as as ource of energy, whereas in others (secondary active transporters) transport is coupled to an electrochemical potentiald ifferencec reatedb y pumping protons or sodium ions from or to the outside of the cell. The transport of ak nown transport substrate can be used to directly monitor the functiono fe fflux pumps, and 5b was thus tested for its ability to inhibitefflux.
After loading EA289 bacteria with the dye 1,2'-dinaphthylamine (1,2'-diNA), which is as ubstrate of the AcrAB-TolC efflux pump, [33] the bacteria fluoresced. Bacteria were then incubated with and without 5b at different concentrations before addition of glucose as an energy source. In the absence of 5b, rapid active transport of more than 80 %o ft he dye was observed( Figure 3d ,b lack line). When 5b was present, significant dose-dependent inhibition was observed (> 80 %r etention at up to 25 mm 5b;F igure 3c,o rangel ine). These results suggest that 5b inhibits the AcrAB-TolC efflux pump.
At ime-kill assay ( Figure 4 ) and ac ell viability assay ( Figure 5 ) were performed in order to evaluatet he bactericidal or bacteriostaticb ehavior of this compound. As shown in Figure 4 , a time kill analysisw as performed against the EA289 bacterial strain by using 5b at af our times the MIC:9 9.9 %d eath (detection limit) occurred by 2h. Ac ell viability assay ( Figure 5 ) was performed by monitoring the irreversible reduction of blue resazurin to red resorufin by viable cells. This conversion is an oxidation-reduction indication in cell viability assays and can serve as an aerobic respiration measurement for bacteria. [34] When using 5b at four times the MIC, there was clearly no cell viability. Thus, the time-kill experiment shows that 5b at four times MIC (200 mm)l ed to ad ecrease in live bacteria after 30 min. When the cells were incubatedf or 60 min at this concentration, the cell viability assay demonstrated total inhibition of respiratory metabolism allowing us to conclude that this decrease in bacterial count correlates highly with cell death.
The real-timea ssay demonstrated the ability of 5b to inhibit efflux transportt oa round6 0% by using as ub-inhibitory concentration (10 mm,M IC/4). The results from the time-killa ssay allow us to state that the cells remainv iable in the efflux assay conditions ( 30 min) and that the inhibition of the dye transport is ac onsequence of as pecific action of the compound.
On the other hand, the nitrocefin hydrolysis and membrane depolarization assays suggest that efflux inhibition is probably due to disruption of membrane integrity therebyl eading to proton-motive force dissipation. Indeed, the hydrolysis kinetics observeda talow concentration of 5b demonstrated as light effect on the membrane, thus correlating with the resultso btained for the depolarization assay.W en oted that outer-membrane permeation increased with increasing 5b concentration, and this is likely responsible for cell death at high levels. We also note that the real-time assays required higherc oncentrations than those for fixed incubation times to generate aquantifiable signal.
Wang et al. recently described as imilara ction of the substituted diamine, 1,13-bis (((2,2-diphenyl)-1-ethyl)thioureido)-4,10-diazatridecane. [35] This diamine compound was also shown to depolarize the cytoplasmic membrane and provide enhanced permeabilization of the outer bacterial membrane. Further structure-activity relationship studies revealed that the central diaminen itrogens werek ey to bioactivity.I nc ontrast to the Nsubstituted systems, the unsubstituted diamines (putrescine and cadaverine) had no antibacterial activity,d id not affect membrane permeability,a nd did not cause membrane rupture. Both of the higher polyamines (spermidine and spermine) were found to be inactive against S. aureus RN4220, P. aeruginosa PAO1and E. coli ANSI. This, when coupled to our findings, suggestst hat either mono-o rd i-substitutedp olyamine systems can serve as antibacterial agents, whereas the unsubstituted native polyamines ystems do not. Ta ken together,o ur studies also suggestt hat the presence of hydrophobic N-substituents is key to the ability of these compounds to target bacterialmembranes and elicit ab acteriocidalr esponse.
Conclusion
Several polyamine derivativeswere investigated for their intrinsic antimicrobiala ctivities against Gram-positive and Gramnegative bacteria. Derivatives 5a and 5b showed excellent activities(MIC 1.56-100 mm).Ina ddition, 5b dramatically affected the antibiotic susceptibility of E. aerogenes, P. aeruginosa,a nd K. pneumoniae MDR strains. We conclude that changes in the transmembrane electrical potential in E. aerogenes EA289 correlate with permeabilization of the cell membrane by motuporamine derivatives, thereby leading to (or concomitantly facilitating) an alteredp rotonh omeostasis. Finally,m otuporamine derivatives such as 5b,t hat are able to disrupt the protong radient, effectively de-energize the effluxp ump and can be considered as efflux-pump inhibitors.
Experimental Section
Bacterial strains: Eight bacterial strains (Institut Pasteur and personal collection) were used in this study.G ram-positive bacteria (S. aureus ATCC25923, S. intermedius 1051997, Enterococcus faecalis ATCC29212) and Gram-negative bacteria (E. coli ATCC28922, P. aeruginosa PAO1, E. aerogenes EA289, aK an derivative of the MDR clinical isolate Ea27, [30] and K. pneumoniae KPC2 ST258) were stored at À80 8Ci ng lycerol (15 %, v/v) . Bacteria were grown in MuellerHinton (MH) broth at 37 8C.
Antibiotics: All the antibiotics were purchased from Sigma-Aldrich except fordoxycycline, which was purchased from TCI Europe (Zwijndrecht, Belgium). All antibiotics were dissolved in water.T he susceptibility of bacterial strains to antibiotics and compounds was determined in microplates by the standard broth dilution method, according to the recommendations of the ComitØ de l'AntibioGramme de la SociØtØ FranÅaise de Microbiologie (CA-SFM). [36] Briefly,M ICs were determined with an inoculum of 10 5 CFU in of MH broth (200 mL) containing twofold serial dilutions of each drug. MIC was defined as the lowest concentration to completely inhibit growth after incubation for 18 ha t3 78C. Measurements were repeated in triplicate.
Determination of antibiotic MIC in the presence of compounds: Briefly,r estoring enhancer concentrations were determined with an inoculum of 5 10 5 CFU in MH broth (200 mL) containing twofold ). The lowest concentration of the polyamine adjuvant that completely inhibited growth after incubation for 18 hat378Cwas determined. Measurements were repeated in triplicate.
Membrane depolarization assays: Bacteria were grown in MH broth for 24 ha t3 78Ca nd centrifuged (3 600 g,2 08C). The pellet was washed twice with buffered HEPES (pH 7.2) sucrose (250 mm) and magnesium sulfate (5 mm). The fluorescent dye 3,3'-diethylthiacarbocyanine iodide was added (3 mm) and allowed to penetrate into bacterial membranes by incubation for 1h of at 37 8C. Cells were then washed to remove the unbound dye before adding 5b at different concentrations. Fluorescence measurements were performed on aF luoroMax 3s pectrofluorometer (Horiba;s lit widths 5/5 nm). The relative corrected fluorescence (RFU) was recorded at 0, 3, 5, 7, 9, 11,1 3, 15, 17, 19, and 21 min. Maximum RFU was that recorded with ap ure solution of the fluorescent dye in buffer (3 mm).
Nitrocefin hydrolysis assay: Outer membrane permeabilization was measured by using nitrocefin, ac hromogenic substrate of periplasmic b-lactamase. MH broth (10 mL) was inoculated with of an overnight culture (0.1 mL) of EA289 and grown at 37 8Ct oO D 600 = 0.5. The remaining steps were performed at room temperature. Cells were recovered by centrifugation (3600 g,2 0min) and washed once with potassium phosphate buffer (PPB;2 0mm, pH 7.2) containing MgCl 2 (1 mm). After another centrifugation, the pellet was resuspended in PPB (100 mL) and adjusted to OD 600 = 0.5. Then, either Polymyxin B( positive control;S igma-Aldrich) or 5b (50 mL) was added to the cell suspension (100 mL) to final concentrations of 0.98-500 mm. Nitrocefin (50 mL, 50 mgmL À1 ;O xoid) was added, and its hydrolysis was monitored spectrophotometrically by measuring the increase in absorbance at 490 nm. Assays were performed in 96-well plates with an M200 Pro spectrophotometer (Tecan).
Glucose-triggered 1,2'-diNA efflux assays: Bacteria were grown to stationary phase, collected by centrifugation, and resuspended to OD 600 = 0.25 in PPB (20 mm,pH7.2) supplemented with carbonyl cyanide m-chlorophenyl hydrazone (CCCP,5 mm;S igma-Aldrich), and incubated overnight with 1,2'-dinaphthylamine (1,2'-diNA, 32 mm;S igma-Aldrich) at 37 8C. Before addition of compound 5b (100 mm), the cells were washed with phosphate buffer.G lucose (50 mm)was added after 300 stoinitiate bacterial energization. Release of membrane-incorporated 1,2'-diNA was followed by monitoring the fluorescence (l ex = 370 nm; l em = 420 nm) every 30 sa t 37 8Ci nan Infinite M200 Pro plate reader (Tecan). Assays were performed in 96-well plates (half area, black with solid bottom, 100 mL per well;Greiner Bio-One).
Measurement of ATPe fflux: Squalamine were prepared in doubly distilled water at different concentrations. As uspension of growing S. aureus or E. aerogenes (EA289) in MH broth was incubated at 37 8C. The suspension (90 mL) was added to squalamine solution synthesized in our laboratory according reported procedures (10 mL), and the mixture was vortexed for 1s.L uciferin-luciferase reagent (Yelen, France;5 0mL) was immediately added, and luminescence was quantified with an Infinite M200 microplate reader (Tecan) for 5s.A TP concentration was quantified by addition of a known amount of ATP( 1mm). As imilar procedure was performed for spermine (100 mgmL À1 )a nd for 5b (200 mm, i.e.,4 MIC).
Time-killing assay: Mid-log phase cultures of EA289 with an inoculum of 10 7 CFU mL were incubated with 5b (4 MIC, 200 mm)a t 37 8Cw ith 160 rpm shaking. Bacterial counts were performed after 0, 15, 30, 90, 120 and 240 min by spreading appropriate dilutions on MH agar plates (detection limit 10 2 CFU mL
À1
). The plates were incubated overnight at 37 8Cb efore colonies were counted. The curves from two independent experiments were averaged and expressed as logarithms (mean AE SE).
Cell viability assay: An overnight culture of EA289 was diluted 100-fold into MHII broth. An inoculum of 10 7 CFU mL À1 was incubated in the presence or absence of 5b (4 MIC, 200 mm)f or 1hat 37 8Cw ith shaking at 160 rpm. The fluorescence of the cell suspension was monitored after addition of CellTiter-Blue reagent (10 %, v/v;P romega). Measurements were performed by using a9 6-well Greiner film-bottom black microplate (Greiner Bio-One) and an Infinite M200 microplate reader (Tecan; l ex = 568 nm and l em = 660 nm). The curves from two independent experiments were combined (mean AE SE).
Synthesis of compounds 4-7:
The synthesis of 4-7 was previously reported. [15, [37] [38] [39] [40] [41] Keywords: antibiotics · antimicrobiala gents · bacterial resistance · membranes · motuporamine · polyamine derivatives
